Pharm
Nitroglycerin Drip
search
Nitroglycerin Drip
, Intravenous Nitroglycerin, Nitroglycerin Infusion
Indications
Acute
Myocardial Ischemia
(
Angina Pectoris
)
Acute
Myocardial Infarction
Limits infarct expansion
Reduces infarct size
Inferior wall
Myocardial Infarction
Congestive Heart Failure
associated with infarction
Decreases vasospasm at site of
Plaque
rupture
Congestive Heart Failure
with
Acute Pulmonary Edema
Hypertensive Emergency
Specifically indicated for
Hypertensive Emergency
with
Acute Pulmonary Edema
Nicardipine
(or
Esmolol
) are indicated as first line agents in most other cases of
Hypertensive Emergency
Contraindications
See
Nitroglycerin
Preparation
Mix 50 mg
Nitroglycerin
in 250 ml D5W (200 mcg/ml)
Pharmacokinetics
Onset in 2 minutes
Duration 3 to 5 minutes
Expect
Blood Pressure
to drop within 3 to 5 minutes of infusion start
Effects wane within 3 to 5 minutes of stopping infusion
Nitroglycerin
is absorbed by polvinyl chloride (PVC) IV tubing, and therefore dosing is increased to compensate for this loss
Use lower doses when non-PVC IV tubing is used
Dosing
Acute
Myocardial Ischemia
or Infarction (Adults)
Bolus: 12.5 to 25 mcg
Nitroglycerin
IV
Consider bolus if
Sublingual Nitroglycerin
has not yet been given
Tittration to maintenance dose
Start: 10 to 20 mcg/min (3-6 ml/hour)
Titrate: Increase 5 to 10 mcg/min every 5 minutes
Usual dosage: 50 to 200 mcg/min (maximum 500 mcg/min)
Endpoints
Blood Pressure
drop over 10%
Adequate decrease in
Systemic Vascular Resistance
Adequate fall in left ventricular filling pressure
Relief of
Chest Pain
Dosing
Hypertensive Emergency
(Adults)
Start
Consider rapid large bolus of 400 mcg/min for 2 minutes OR
Start 10 to 20 mcg/min and titrate to 100 mcg/min
Next
Decrease dose to 100 to 150 mcg/minute
Observe for effect and be ready to decrease dose
Cummulative bolus dose in
Hypertensive Emergency
approaches 400 mcg over 5 minutes
Dosing
Children (Not FDA Approved)
Start 0.25 to 0.5 mcg/kg/min
Increase by 0.5 to 1 mcg/kg/min every 3 to 5 min as needed
Maximum 5 mcg/kg/min
Adverse Effects
See
Nitroglycerin
Mechanism
See
Nitroglycerin
Safety
Pregnancy Category C
Unknown safety in
Lactation
Adverse Effects
See
Nitroglycerin
Safety
Pregnancy Category C
Unknown Safety in
Lactation
Resources
Nitroglycerin Infusion (Dailymed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c52cdf6-87be-4719-b105-f08be096d462
References
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 70-1
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here